Sign up to save your podcasts
Or
Share CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.
We love to hear from our listeners. Send us a message.
Applications (BLAs) of recent approvals and complete responses for novel products or rare diseases as well as BLAs currently under review. Benton shares information about FDA Draft Gudiances, including Platform Technology Designation Program for Drug Development: Guidance for Industry. She also provides a regulatory outlook for CGT developers.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Applications (BLAs) of recent approvals and complete responses for novel products or rare diseases as well as BLAs currently under review. Benton shares information about FDA Draft Gudiances, including Platform Technology Designation Program for Drug Development: Guidance for Industry. She also provides a regulatory outlook for CGT developers.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
764 Listeners
Freakonomics Radio
32,056 Listeners
a16z Podcast
1,004 Listeners
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
523 Listeners
Acquired
3,548 Listeners
Pivot
8,326 Listeners
The Long Run with Luke Timmerman
116 Listeners
The Readout Loud
314 Listeners
Biotech 2050 Podcast
59 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
8,214 Listeners
Business Of Biotech
82 Listeners
BioCentury This Week
27 Listeners
Raising Health
143 Listeners
ASGCT Podcast Network
14 Listeners
Ground Truths
44 Listeners